查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1459811

外用抗生素市場（藥品類別：四環素、氨基糖苷類、紅黴素、克林黴素等；產品類型：處方藥和非處方藥）- 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢和預測

Topical Antibiotics Market (Drug Class: Tetracycline, Amino-glycosides, Erythromycin, Clindamycin, and Others; and Product Type: Prescription and OTC) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 232 Pages | 商品交期: 2-10個工作天內

價格

外用抗生素市場 - 報告範圍

TMR 關於全球外用抗生素市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球外用抗生素市場的收入2017-2031年期間，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球外用抗生素市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解局部抗生素市場。

市場概況
2022年市場價​​值 65 億美元
2031 年市場價值 100 億美元
CAGR 5.1%

該報告深入探討了全球外用抗生素市場的競爭格局。全球外用抗生素市場的主要參與者已經確定，並對每位參與者的不同屬性進行了分析。公司概況、財務狀況、近期發展和 SWOT 是本報告中介紹的全球局部抗生素市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 主要產品/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依藥物類別

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依藥品類別，2017-2031
    • 四環素
    • 氨基糖苷類
    • 紅黴素
    • 克林黴素
    • 其他
  • 市場吸引力：按藥品類別

第 7 章：全球市場分析與預測：按劑型

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：按劑型，2017-2031
    • 藥膏
    • 乳霜
    • 粉末
    • 凝膠
    • 其他
    • 7.4 市場吸引力：按劑型

第 8 章：全球市場分析與預測：依指標分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依指標分類，2017-2031
    • 皮膚感染
    • 眼部感染
    • 狐狸臭
    • 其他
  • 市場吸引力：依指標分類

第 9 章：全球市場分析與預測：依產品類型

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依產品類型，2017-2031
    • 處方
    • 場外交易
  • 市場吸引力：按產品類型

第 10 章：全球市場分析與預測：按配銷通路

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：按配銷通路，2017-2031
    • 醫院藥房
    • 零售藥局
    • 其他
  • 市場吸引力：按配銷通路分類

第 11 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力：按地區

第 12 章：北美市場分析與預測

第 13 章：歐洲市場分析與預測

第 14 章：亞太市場分析與預測

第 15 章：拉丁美洲市場分析與預測

第 16 章：中東和非洲市場分析與預測

第17章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • Novartis AG
    • GlaxoSmithKline plc
    • Perrigo Company plc
    • Pfizer, Inc.
    • Almirall, SA
    • Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
    • Medimetriks Pharmaceuticals, Inc.
    • Taro Pharmaceutical Industries Ltd.
    • Mayne Pharma Group Ltd.
Product Code: TMRGL44919

Topical Antibiotics Market - Scope of Report

TMR's report on the global topical antibiotics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global topical antibiotics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global topical antibiotics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the topical antibiotics market.

Market Snapshot
Market Value in 2022US$ 6.5 Bn
Market Value in 2031US$ 10 Bn
CAGR5.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global topical antibiotics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global topical antibiotics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global topical antibiotics market.

The report delves into the competitive landscape of the global topical antibiotics market. Key players operating in the global topical antibiotics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global topical antibiotics market profiled in this report.

Key Questions Answered in Global topical antibiotics Market Report:

  • What is the sales/revenue generated by topical antibiotics across all regions during the forecast period?
  • What are the opportunities in the global topical antibiotics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Topical Antibiotics Market - Research Objectives and Research Approach

The comprehensive report on the global topical antibiotics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global topical antibiotics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global topical antibiotics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Topical Antibiotics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Topical Antibiotics Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Topical Antibiotics Market Analysis and Forecast, by Drug Class

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Drug Class, 2017-2031
    • 6.3.1. Tetracycline
    • 6.3.2. Amino-glycosides
    • 6.3.3. Erythromycin
    • 6.3.4. Clindamycin
    • 6.3.5. Others
  • 6.4. Market Attractiveness, by Drug Class

7. Global Topical Antibiotics Market Analysis and Forecast, by Dosage Form

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 7.3.1. Ointments
    • 7.3.2. Creams
    • 7.3.3. Powders
    • 7.3.4. Gels
    • 7.3.5. Others
    • 7.3.6. 7.4 Market Attractiveness, by Dosage Form

8. Global Topical Antibiotics Market Analysis and Forecast, By Indication

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, By Indication, 2017-2031
    • 8.3.1. Skin Infection
    • 8.3.2. Eye Infection
    • 8.3.3. Bromhidrosis
    • 8.3.4. Others
  • 8.4. Market Attractiveness, By Indication

9. Global Topical Antibiotics Market Analysis and Forecast, by Product Type

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Product Type, 2017-2031
    • 9.3.1. Prescription
    • 9.3.2. OTC
  • 9.4. Market Attractiveness, by Product Type

10. Global Topical Antibiotics Market Analysis and Forecast, by Distribution Channel

  • 10.1. Introduction and Definitions
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Others
  • 10.4. Market Attractiveness, by Distribution Channel

11. Global Topical Antibiotics Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2017-2031
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Region

12. North America Topical Antibiotics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Drug Class, 2017-2031
    • 12.2.1. Tetracycline
    • 12.2.2. Amino-glycosides
    • 12.2.3. Erythromycin
    • 12.2.4. Clindamycin
    • 12.2.5. Others
  • 12.3. Market Attractiveness, by Drug Class
  • 12.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 12.4.1. Ointments
    • 12.4.2. Creams
    • 12.4.3. Powders
    • 12.4.4. Gels
    • 12.4.5. Others
  • 12.5. Market Attractiveness, by Dosage Form
  • 12.6. Market Value Forecast, By Indication, 2017-2031
    • 12.6.1. Skin Infection
    • 12.6.2. Eye Infection
    • 12.6.3. Bromhidrosis
    • 12.6.4. Others
  • 12.7. Market Attractiveness, By Indication
  • 12.8. Market Value Forecast, by Product Type, 2017-2031
    • 12.8.1. Prescription
    • 12.8.2. OTC
  • 12.9. Market Attractiveness, by Product Type
  • 12.10. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.10.1. Hospital Pharmacies
    • 12.10.2. Retail Pharmacies
    • 12.10.3. Others
  • 12.11. Market Attractiveness, by Distribution Channel
  • 12.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.12.1. U.S.
    • 12.12.2. Canada
  • 12.13. Market Attractiveness Analysis
    • 12.13.1. By Drug Class
    • 12.13.2. By Dosage Form
    • 12.13.3. By Indication
    • 12.13.4. By Product Type
    • 12.13.5. By Distribution Channel
    • 12.13.6. By Country

13. Europe Topical Antibiotics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Drug Class, 2017-2031
    • 13.2.1. Tetracycline
    • 13.2.2. Amino-glycosides
    • 13.2.3. Erythromycin
    • 13.2.4. Clindamycin
    • 13.2.5. Others
  • 13.3. Market Attractiveness, by Drug Class
  • 13.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 13.4.1. Ointments
    • 13.4.2. Creams
    • 13.4.3. Powders
    • 13.4.4. Gels
    • 13.4.5. Others
  • 13.5. Market Attractiveness, by Dosage Form
  • 13.6. Market Value Forecast, By Indication, 2017-2031
    • 13.6.1. Skin Infection
    • 13.6.2. Eye Infection
    • 13.6.3. Bromhidrosis
    • 13.6.4. Others
  • 13.7. Market Attractiveness, By Indication
  • 13.8. Market Value Forecast, by Product Type, 2017-2031
    • 13.8.1. Prescription
    • 13.8.2. OTC
  • 13.9. Market Attractiveness, by Product Type
  • 13.10. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.10.1. Hospital Pharmacies
    • 13.10.2. Retail Pharmacies
    • 13.10.3. Others
  • 13.11. Market Attractiveness, by Distribution Channel
  • 13.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.12.1. Germany
    • 13.12.2. U.K.
    • 13.12.3. France
    • 13.12.4. Italy
    • 13.12.5. Spain
    • 13.12.6. Rest of Europe
  • 13.13. Market Attractiveness Analysis
    • 13.13.1. By Drug Class
    • 13.13.2. By Dosage Form
    • 13.13.3. By Indication
    • 13.13.4. By Product Type
    • 13.13.5. By Distribution Channel
    • 13.13.6. By Country/Sub-region

14. Asia Pacific Topical Antibiotics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Drug Class, 2017-2031
    • 14.2.1. Tetracycline
    • 14.2.2. Amino-glycosides
    • 14.2.3. Erythromycin
    • 14.2.4. Clindamycin
    • 14.2.5. Others
  • 14.3. Market Attractiveness, by Drug Class
  • 14.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 14.4.1. Ointments
    • 14.4.2. Creams
    • 14.4.3. Powders
    • 14.4.4. Gels
    • 14.4.5. Others
  • 14.5. Market Attractiveness, by Dosage Form
  • 14.6. Market Value Forecast, By Indication, 2017-2031
    • 14.6.1. Skin Infection
    • 14.6.2. Eye Infection
    • 14.6.3. Bromhidrosis
    • 14.6.4. Others
  • 14.7. Market Attractiveness, By Indication
  • 14.8. Market Value Forecast, by Product Type, 2017-2031
    • 14.8.1. Prescription
    • 14.8.2. OTC
  • 14.9. Market Attractiveness, by Product Type
  • 14.10. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.10.1. Hospital Pharmacies
    • 14.10.2. Retail Pharmacies
    • 14.10.3. Others
  • 14.11. Market Attractiveness, by Distribution Channel
  • 14.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.12.1. China
    • 14.12.2. Japan
    • 14.12.3. India
    • 14.12.4. Australia & New Zealand
    • 14.12.5. Rest of Asia Pacific
  • 14.13. Market Attractiveness Analysis
    • 14.13.1. By Drug Class
    • 14.13.2. By Dosage Form
    • 14.13.3. By Indication
    • 14.13.4. By Product Type
    • 14.13.5. By Distribution Channel
    • 14.13.6. By Country/Sub-region

15. Latin America Topical Antibiotics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Drug Class, 2017-2031
    • 15.2.1. Tetracycline
    • 15.2.2. Amino-glycosides
    • 15.2.3. Erythromycin
    • 15.2.4. Clindamycin
    • 15.2.5. Others
  • 15.3. Market Attractiveness, by Drug Class
  • 15.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 15.4.1. Ointments
    • 15.4.2. Creams
    • 15.4.3. Powders
    • 15.4.4. Gels
    • 15.4.5. Others
  • 15.5. Market Attractiveness, by Dosage Form
  • 15.6. Market Value Forecast, By Indication, 2017-2031
    • 15.6.1. Skin Infection
    • 15.6.2. Eye Infection
    • 15.6.3. Bromhidrosis
    • 15.6.4. Others
  • 15.7. Market Attractiveness, By Indication
  • 15.8. Market Value Forecast, by Product Type, 2017-2031
    • 15.8.1. Prescription
    • 15.8.2. OTC
  • 15.9. Market Attractiveness, by Product Type
  • 15.10. Market Value Forecast, by Distribution Channel, 2017-2031
    • 15.10.1. Hospital Pharmacies
    • 15.10.2. Retail Pharmacies
    • 15.10.3. Others
  • 15.11. Market Attractiveness, by Distribution Channel
  • 15.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.12.1. Brazil
    • 15.12.2. Mexico
    • 15.12.3. Rest of Latin America
  • 15.13. Market Attractiveness Analysis
    • 15.13.1. By Drug Class
    • 15.13.2. By Dosage Form
    • 15.13.3. By Indication
    • 15.13.4. By Product Type
    • 15.13.5. By Distribution Channel
    • 15.13.6. By Country/Sub-region

16. Middle East & Africa Topical Antibiotics Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Drug Class, 2017-2031
    • 16.2.1. Tetracycline
    • 16.2.2. Amino-glycosides
    • 16.2.3. Erythromycin
    • 16.2.4. Clindamycin
    • 16.2.5. Others
  • 16.3. Market Attractiveness, by Drug Class
  • 16.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 16.4.1. Ointments
    • 16.4.2. Creams
    • 16.4.3. Powders
    • 16.4.4. Gels
    • 16.4.5. Others
  • 16.5. Market Attractiveness, by Dosage Form
  • 16.6. Market Value Forecast, By Indication, 2017-2031
    • 16.6.1. Skin Infection
    • 16.6.2. Eye Infection
    • 16.6.3. Bromhidrosis
    • 16.6.4. Others
  • 16.7. Market Attractiveness, By Indication
  • 16.8. Market Value Forecast, by Product Type, 2017-2031
    • 16.8.1. Prescription
    • 16.8.2. OTC
  • 16.9. Market Attractiveness, by Product Type
  • 16.10. Market Value Forecast, by Distribution Channel, 2017-2031
    • 16.10.1. Hospital Pharmacies
    • 16.10.2. Retail Pharmacies
    • 16.10.3. Others
  • 16.11. Market Attractiveness, by Distribution Channel
  • 16.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.12.1. GCC Countries
    • 16.12.2. South Africa
    • 16.12.3. Rest of Middle East & Africa
  • 16.13. Market Attractiveness Analysis
    • 16.13.1. By Drug Class
    • 16.13.2. By Dosage Form
    • 16.13.3. By Indication
    • 16.13.4. By Product Type
    • 16.13.5. By Distribution Channel
    • 16.13.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. Novartis AG
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. GlaxoSmithKline plc
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. Perrigo Company plc
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Pfizer, Inc.
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. Almirall, SA
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. Medimetriks Pharmaceuticals, Inc.
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Taro Pharmaceutical Industries Ltd.
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. Mayne Pharma Group Ltd.
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 02: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 03: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 04: Global Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017-2031
  • Table 05: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 06: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 09: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 10: North America Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017-2031
  • Table 11: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 12: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 15: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 16: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017-2031
  • Table 17: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 18: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 19: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 21: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 22: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017-2031
  • Table 23: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 24: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 25: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 27: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 28: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017-2031
  • Table 29: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 30: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 31: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 33: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 34: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017-2031
  • Table 35: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 36: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Topical Antibiotics Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Topical Antibiotics Market Revenue (US$ Mn), by Drug Class, 2022
  • Figure 03: Global Topical Antibiotics Market Value Share, by Drug Class, 2022
  • Figure 04: Global Topical Antibiotics Market Revenue (US$ Mn), by Dosage Form, 2022
  • Figure 05: Global Topical Antibiotics Market Value Share, by Dosage Form, 2022
  • Figure 06: Global Topical Antibiotics Market Revenue (US$ Mn), By Indication, 2022
  • Figure 07: Global Topical Antibiotics Market Value Share, By Indication, 2022
  • Figure 08: Global Topical Antibiotics Market Revenue (US$ Mn), by Product Type, 2022
  • Figure 09: Global Topical Antibiotics Market Value Share, by Product Type, 2022
  • Figure 10: Global Topical Antibiotics Market Revenue (US$ Mn), by Distribution Channel, 2022
  • Figure 11: Global Topical Antibiotics Market Value Share, by Distribution Channel, 2022
  • Figure 12: Global Topical Antibiotics Market Value Share, by Region, 2022
  • Figure 13: Global Topical Antibiotics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 14: Global Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022-2031
  • Figure 15: Global Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 16: Global Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022-2031
  • Figure 17: Global Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 18: Global Topical Antibiotics Market Value Share Analysis, By Indication, 2022-2031
  • Figure 19: Global Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
  • Figure 20: Global Topical Antibiotics Market Revenue (US$ Mn), by Product Type, 2022
  • Figure 21: Global Topical Antibiotics Market Value Share, by Product Type, 2022
  • Figure 22: Global Topical Antibiotics Market Revenue (US$ Mn), by Distribution Channel, 2022
  • Figure 23: Global Topical Antibiotics Market Value Share, by Distribution Channel, 2022
  • Figure 24: Global Topical Antibiotics Market Value Share Analysis, by Region, 2022-2031
  • Figure 25: Global Topical Antibiotics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 26: North America Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 27: North America Topical Antibiotics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Topical Antibiotics Market Value Share Analysis, by Country, 2022-2031
  • Figure 29: North America Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022-2031
  • Figure 30: North America Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022-2031
  • Figure 31: North America Topical Antibiotics Market Value Share Analysis, By Indication, 2022-2031
  • Figure 32: North America Topical Antibiotics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 33: North America Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 34: North America Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 35: North America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 36: North America Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
  • Figure 37: North America Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 38: North America Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 39: Europe Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 40: Europe Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 41: Europe Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 42: Europe Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022-2031
  • Figure 43: Europe Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022-2031
  • Figure 44: Europe Topical Antibiotics Market Value Share Analysis, By Indication, 2022-2031
  • Figure 45: Europe Topical Antibiotics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 46: Europe Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 47: Europe Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 48: Europe Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 49: Europe Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
  • Figure 50: Europe Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 51: Europe Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 52: Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 53: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 54: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 55: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022-2031
  • Figure 56: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022-2031
  • Figure 57: Asia Pacific Topical Antibiotics Market Value Share Analysis, By Indication, 2022-2031
  • Figure 58: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 59: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 60: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 61: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 62: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
  • Figure 63: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 64: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 65: Latin America Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 66: Latin America Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 67: Latin America Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 68: Latin America Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022-2031
  • Figure 69: Latin America Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022-2031
  • Figure 70: Latin America Topical Antibiotics Market Value Share Analysis, By Indication, 2022-2031
  • Figure 71: Latin America Topical Antibiotics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 72: Latin America Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 73: Latin America Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 74: Latin America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 75: Latin America Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
  • Figure 76: Latin America Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 77: Latin America Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 78: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 79: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 80: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 81: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022-2031
  • Figure 82: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022-2031
  • Figure 83: Middle East & Africa Topical Antibiotics Market Value Share Analysis, By Indication, 2022-2031
  • Figure 84: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 85: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 86: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 87: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 88: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
  • Figure 89: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 90: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023-2031